Income Statement Garofalo Health Care S.p.A.

Stocks

GHC

IT0005345233

Healthcare Facilities & Services

Market Closed - Borsa Italiana Other stock markets 11:45:00 2026-07-10 am EDT			5-day change	1st Jan Change
5.480 ^EUR	+0.37%		0.00%	-1.97%

Jun. 18	Mixed Start for European Markets; London Lags Behind	AN
May. 14	Garofalo Health Care S.p.A. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI

f.gERJtpSE-PB9fWc4JmcjDpPd3fjgK-v4tBu15jXL8EI.9yAu98DAgbMlSlV5QgRzOMO_kpW2TaqNjC_3rW-pqDrBASHp9u2xvRolXw

Published financial data: GAROFALO HEALTH CARE S.P.A.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	278M	315M	361M	462M	479M
Other Revenues, Total	3.82M	5.28M	5.16M	5.59M	6.29M
Total Revenues	282M	320M	366M	468M	485M
Cost of Goods Sold, Total	218M	249M	285M	368M	381M
Gross Profit	63.24M	71.29M	80.68M	99.83M	104M
Selling General & Admin Expenses, Total	670K	829K	890K	1.01M	982K
Depreciation & Amortization - (IS)	15.52M	18.36M	21.44M	25.33M	27.9M
Other Operating Expenses	13.23M	12.23M	14.47M	23.77M	23.15M
Other Operating Expenses, Total	29.42M	31.42M	36.8M	50.11M	52.03M
Operating Income	33.83M	39.87M	43.88M	49.72M	51.86M
Interest Expense, Total	-4.21M	-4.2M	-10.29M	-13.92M	-10.84M
Interest And Investment Income	3K	19K	282K	1.07M	482K
Net Interest Expenses	-4.21M	-4.18M	-10.01M	-12.86M	-10.36M
Income (Loss) On Equity Invest.	213K	129K	173K	123K	81K
Other Non Operating Income (Expenses)	-245K	-239K	-461K	-709K	-907K
EBT, Excl. Unusual Items	29.59M	35.57M	33.58M	36.28M	40.68M
Gain (Loss) On Sale Of Investments	-	-	-	-15K	-
Gain (Loss) On Sale Of Assets	58K	137K	84K	610K	224K
Asset Writedown	-187K	-599K	-1.67M	-826K	-1.05M
Insurance Settlements	-	188K	34K	35K	92K
Legal Settlements	-2.73M	-3.78M	-2.39M	-5.4M	-5.98M
Other Unusual Items	-2.74M	-2.64M	-703K	-	-
EBT, Incl. Unusual Items	23.99M	28.88M	28.93M	30.68M	33.96M
Income Tax Expense	5.14M	7.44M	8.06M	8.84M	10.39M
Earnings From Continuing Operations	18.84M	21.43M	20.87M	21.85M	23.57M
Net Income to Company	18.84M	21.43M	20.87M	21.85M	23.57M
Minority Interest	-9K	-7K	-74K	-146K	-159K
Net Income - (IS)	18.83M	21.43M	20.8M	21.7M	23.41M
Net Income to Common Incl Extra Items	18.83M	21.43M	20.8M	21.7M	23.41M
Net Income to Common Excl. Extra Items	18.83M	21.43M	20.8M	21.7M	23.41M
Per Share Items
Net EPS - Basic	0.21	0.24	0.23	0.25	0.26
Basic EPS - Continuing Operations	0.21	0.24	0.23	0.25	0.26
Basic Weighted Average Shares Outstanding	89.23M	88.9M	88.55M	88.47M	88.59M
Net EPS - Diluted	0.21	0.24	0.18	0.24	0.26
Diluted EPS - Continuing Operations	0.21	0.24	0.18	0.24	0.26
Diluted Weighted Average Shares Outstanding	89.23M	88.9M	88.55M	89.35M	89.73M
Normalized Basic EPS	0.21	0.25	0.24	0.25	0.29
Normalized Diluted EPS	0.21	0.25	0.24	0.25	0.28
Dividend Per Share	-	-	-	0.09	0.09
Payout Ratio	-	-	-	-	32.42
Supplemental Items
EBITDA	46.44M	55.05M	61.6M	70.92M	75.15M
EBITA	34.14M	40.12M	44.09M	49.92M	52.19M
EBIT	33.83M	39.87M	43.88M	49.72M	51.86M
EBITDAR	47.11M	55.88M	62.49M	71.93M	76.13M
Total Revenues (As Reported)	284M	323M	369M	471M	487M
Effective Tax Rate - (Ratio)	21.45	25.77	27.85	28.8	30.61
Current Domestic Taxes	5.4M	-	7.44M	7.37M	9.84M
Total Current Taxes	5.4M	6.44M	7.44M	7.37M	9.84M
Deferred Domestic Taxes	-428K	-	417K	1.05M	502K
Total Deferred Taxes	-428K	-1.3M	417K	1.05M	502K
Normalized Net Income	18.48M	22.22M	20.91M	22.53M	25.26M
Interest on Long-Term Debt	2.23M	3.13M	7.69M	2.22M	3.92M
Non-Cash Pension Expense	65K	45K	-	-	296K
Supplemental Operating Expense Items
Research And Development Expense From Footnotes	-	205K	199K	192K	190K
Net Rental Expense, Total	670K	829K	890K	1.01M	982K
Imputed Operating Lease Interest Expense	148K	155K	362K	440K	374K
Imputed Operating Lease Depreciation	522K	674K	528K	567K	608K
Maintenance & Repair Expenses, Total	4.7M	5.16M	6.01M	7.32M	7.24M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	41.24M	31.38M	22.68M	26.66M	19.88M
Short Term Investments	-	-	-	-	-
Total Cash And Short Term Investments	41.24M	31.38M	22.68M	26.66M	19.88M
Accounts Receivable, Total	74.72M	76.48M	101M	113M	118M
Other Receivables	5.5M	4.66M	10.49M	7.72M	8.13M
Total Receivables	80.22M	81.14M	111M	121M	126M
Inventory	4.32M	4.24M	5.58M	6.07M	6.22M
Prepaid Expenses	1.4M	1.58M	-	-	-
Other Current Assets, Total	2.76M	3.05M	5.51M	11.18M	15.58M
Total Current Assets	130M	121M	145M	164M	168M
Net Property Plant And Equipment	217M	222M	253M	294M	301M
Long-term Investments	1.28M	826K	3.78M	1.36M	1.34M
Goodwill	70.26M	91.39M	156M	91.54M	91.54M
Other Intangibles, Total	196M	196M	219M	281M	282M
Deferred Tax Assets Long-Term	9.66M	10.62M	14.85M	14M	12.81M
Other Long-Term Assets, Total	2.52M	3.73M	4.06M	3.6M	3.36M
Total Assets	627M	646M	796M	850M	860M
Liabilities
Accounts Payable, Total	46.24M	51.1M	87.85M	86.41M	82.22M
Accrued Expenses, Total	13.91M	14.14M	18.35M	18.46M	20.15M
Short-term Borrowings	19.11M	16.28M	16.72M	26.67M	18K
Current Portion of Long-Term Debt	21.5M	22.15M	42.15M	1.13M	1.24M
Current Portion of Leases	4.84M	5.86M	5.27M	4.9M	4.57M
Current Income Taxes Payable	3.04M	2.45M	3.47M	2.75M	4.87M
Other Current Liabilities	21.56M	19.25M	30.6M	4.53M	23.51M
Total Current Liabilities	130M	131M	204M	145M	137M
Long-Term Debt	117M	110M	142M	201M	200M
Long-Term Leases	21.56M	21.62M	21.94M	22.44M	19.11M
Pension & Other Post Retirement Benefits	12.07M	13.6M	19.5M	15.95M	14.09M
Deferred Tax Liability Non Current	67.93M	67.36M	74.77M	104M	103M
Other Non Current Liabilities	17.47M	22.39M	32.75M	29.16M	36.34M
Total Liabilities	366M	367M	495M	517M	510M
Common Stock, Total	31.57M	31.57M	31.57M	31.57M	31.57M
Additional Paid In Capital	107M	107M	107M	107M	107M
Retained Earnings	87.08M	109M	130M	151M	168M
Treasury Stock	-4.87M	-6.11M	-7.6M	-8.11M	-8.82M
Comprehensive Income and Other	40.12M	38.23M	38.7M	40.94M	41.83M
Total Common Equity	260M	279M	299M	322M	339M
Minority Interest	262K	83K	2M	10.75M	10.88M
Total Equity	261M	279M	301M	333M	350M
Total Liabilities And Equity	627M	646M	796M	850M	860M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	89.23M	88.9M	88.55M	88.47M	88.33M
ECS Total Common Shares Outstanding	89.23M	88.9M	88.55M	88.47M	88.33M
Book Value / Share	2.92	3.14	3.38	3.64	3.84
Tangible Book Value	-5.64M	-8.36M	-76.38M	-50.59M	-34.46M
Tangible Book Value Per Share	-0.06	-0.09	-0.86	-0.57	-0.39
Total Debt	184M	176M	228M	256M	225M
Net Debt	142M	145M	205M	229M	206M
Debt Equivalent Oper. Leases	5.36M	6.63M	7.12M	8.06M	7.86M
Minority Interest, Total (Incl. Fin. Div)	262K	83K	2M	10.75M	10.88M
Equity Method Investments, Total	809K	735K	1.29M	1.28M	1.25M
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	4.32M	4.24M	5.58M	6.07M	6.22M
Full Time Employees	1.86K	1.91K	2.77K	2.34K	2.33K
Part Time Employees	-	-	-	364	385
Accumulated Allowance for Doubtful Accounts (Supple)	6.64M	7.06M	11.46M	11.98M	11.41M

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	18.83M	21.43M	20.8M	21.7M	23.41M
Depreciation & Amortization - CF	14.85M	17.42M	20.35M	23.9M	26M
Amortization of Goodwill and Intangible Assets - (CF)	312K	256K	213K	208K	327K
Depreciation & Amortization, Total	15.16M	17.68M	20.56M	24.11M	26.32M
Amortization of Deferred Charges, Total - (CF)	359K	688K	878K	1.23M	1.58M
(Income) Loss On Equity Investments - (CF)	-213K	-129K	-173K	-123K	-81K
Provision and Write-off of Bad Debts	187K	599K	1.67M	826K	-61K
Other Operating Activities, Total	-808K	5.02M	846K	1.42M	11.49M
Change In Accounts Receivable	-2.71M	-1.91M	4.96M	-12.67M	-4.84M
Change In Inventories	341K	191K	170K	-490K	-148K
Change In Accounts Payable	-881K	3.88M	-2.54M	-1.44M	-4.19M
Change in Other Net Operating Assets	6.04M	-3.56M	2.83M	442K	-4.44M
Cash from Operations	36.31M	43.87M	50.01M	34.99M	49.04M
Capital Expenditure	-23.2M	-13.84M	-15.44M	-18.29M	-30.92M
Sale of Property, Plant, and Equipment	326K	316K	271K	791K	272K
Cash Acquisitions	-67.68M	-20.88M	-49.96M	-	-
Sale (Purchase) of Intangible assets	-1.47M	-1.13M	-1.71M	-3.3M	-2.62M
Investment in Marketable and Equity Securities, Total	-388K	-169K	-1.14M	2.45M	102K
Other Investing Activities, Total	281K	203K	80K	-	-810K
Cash from Investing	-92.13M	-35.5M	-67.9M	-18.36M	-33.97M
Short Term Debt Issued, Total	6.93M	-	431K	-	-
Long-Term Debt Issued, Total	180M	16.59M	40.68M	178M	-
Total Debt Issued	187M	16.59M	41.11M	178M	-
Short Term Debt Repaid, Total	-	-2.82M	-	-16.57M	-126K
Long-Term Debt Repaid, Total	-152M	-29.01M	-30.39M	-173M	-1.13M
Total Debt Repaid	-152M	-31.83M	-30.39M	-190M	-1.25M
Issuance of Common Stock	40.94M	-	-	-	-
Repurchase of Common Stock	-3.15M	-2.98M	-1.49M	-849K	-1.3M
Common Dividends Paid	-	-	-	-	-7.59M
Common & Preferred Stock Dividends Paid	-	-	-	-	-7.59M
Other Financing Activities, Total	-27K	-10K	-24K	-	-11.71M
Cash from Financing	72.24M	-18.23M	9.2M	-12.66M	-21.85M
Miscellaneous Cash Flow Adjustments	-	-	-1K	1K	-
Net Change in Cash	16.43M	-9.86M	-8.7M	3.98M	-6.78M
Supplemental Items
Cash Interest Paid	2.16M	2.31M	7.89M	9.84M	9.6M
Cash Income Tax Paid (Refund)	3.68M	6.92M	7.24M	8.69M	6.87M
Levered Free Cash Flow	15.28M	26.58M	46.05M	9M	2.22M
Unlevered Free Cash Flow	17.91M	29.21M	52.48M	17.71M	8.99M
Change In Net Working Capital	-5.92M	-898K	-20.76M	17.1M	17.78M
Net Debt Issued / Repaid	34.48M	-15.24M	10.72M	-11.81M	-1.25M

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	3.89	3.92	3.8	3.77	3.79
Return on Total Capital	5.49	5.54	5.57	5.43	5.7
Return On Equity %	8.12	7.94	7.2	6.89	6.9
Return on Common Equity	8.12	7.94	7.2	6.99	7.08
Margin Analysis
Gross Profit Margin %	22.45	22.28	22.04	21.34	21.42
SG&A Margin	0.24	0.26	0.24	0.22	0.2
EBITDA Margin %	16.49	17.2	16.83	15.16	15.49
EBITA Margin %	12.12	12.54	12.04	10.67	10.76
EBIT Margin %	12.01	12.46	11.98	10.63	10.69
Income From Continuing Operations Margin %	6.69	6.7	5.7	4.67	4.86
Net Income Margin %	6.69	6.69	5.68	4.64	4.83
Net Avail. For Common Margin %	6.69	6.69	5.68	4.64	4.83
Normalized Net Income Margin	6.56	6.94	5.71	4.82	5.21
Levered Free Cash Flow Margin	5.42	8.31	12.58	1.92	0.46
Unlevered Free Cash Flow Margin	6.36	9.13	14.33	3.79	1.85
Asset Turnover
Asset Turnover	0.52	0.5	0.51	0.57	0.57
Fixed Assets Turnover	1.5	1.46	1.54	1.71	1.63
Receivables Turnover (Average Receivables)	4.08	4.16	4.07	4.32	4.15
Inventory Turnover (Average Inventory)	55.95	58.08	58.1	63.13	62.02
Short Term Liquidity
Current Ratio	1	0.92	0.71	1.14	1.23
Quick Ratio	0.93	0.86	0.66	1.02	1.07
Operating Cash Flow to Current Liabilities	0.28	0.33	0.24	0.24	0.36
Days Sales Outstanding (Average Receivables)	89.41	87.66	89.73	84.67	87.88
Days Outstanding Inventory (Average Inventory)	6.52	6.28	6.28	5.8	5.89
Average Days Payable Outstanding	68.33	71.44	88.42	86.56	80.69
Cash Conversion Cycle (Average Days)	27.61	22.51	7.58	3.91	13.08
Long Term Solvency
Total Debt/Equity	70.41	63.18	75.78	76.86	64.44
Total Debt / Total Capital	41.32	38.72	43.11	43.46	39.19
LT Debt/Equity	52.98	47.32	54.47	67.04	62.78
Long-Term Debt / Total Capital	31.09	29	30.99	37.91	38.18
Total Liabilities / Total Assets	58.39	56.78	62.21	60.82	59.32
EBIT / Interest Expense	8.03	9.48	4.26	3.57	4.78
EBITDA / Interest Expense	11.63	13.69	6.26	5.3	7.21
(EBITDA - Capex) / Interest Expense	6.12	10.4	4.76	3.99	4.36
Total Debt / EBITDA	3.75	3.07	3.54	3.47	2.88
Net Debt / EBITDA	2.91	2.52	3.19	3.11	2.63
Total Debt / (EBITDA - Capex)	7.12	4.04	4.65	4.61	4.77
Net Debt / (EBITDA - Capex)	5.52	3.32	4.19	4.13	4.35
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	35.21	13.12	14.4	27.76	3.71
Gross Profit, 1 Yr. Growth %	61.16	17.82	17.53	24.81	4.07
EBITDA, 1 Yr. Growth %	62.61	14.46	13.89	9.75	0.14
EBITA, 1 Yr. Growth %	96.25	20.67	20.25	12.78	2.03
EBIT, 1 Yr. Growth %	99.32	22.37	22.83	15.14	4.31
Earnings From Cont. Operations, 1 Yr. Growth %	59.9	13.75	-2.61	4.67	7.87
Net Income, 1 Yr. Growth %	59.87	13.76	-2.93	4.34	7.87
Normalized Net Income, 1 Yr. Growth %	103.97	25.56	6.51	10.02	12.15
Diluted EPS Before Extra, 1 Yr. Growth %	50	14.29	-25	33.33	8.33
Accounts Receivable, 1 Yr. Growth %	21.67	2.35	32.05	11.73	4.34
Inventory, 1 Yr. Growth %	23.95	-1.8	31.55	8.78	2.44
Net Property, Plant and Equip., 1 Yr. Growth %	36.34	2.22	14.05	16.13	2.58
Total Assets, 1 Yr. Growth %	36.24	3.08	23.29	6.78	1.13
Tangible Book Value, 1 Yr. Growth %	-165.67	48.23	813.62	-33.76	-31.88
Common Equity, 1 Yr. Growth %	28.2	7.15	7.1	7.87	5.12
Cash From Operations, 1 Yr. Growth %	58.14	20.81	13.99	-30.02	40.15
Capital Expenditures, 1 Yr. Growth %	110.99	-40.36	11.59	18.48	69.04
Levered Free Cash Flow, 1 Yr. Growth %	33.64	83.37	91.93	-53.46	-93.76
Unlevered Free Cash Flow, 1 Yr. Growth %	37.59	70.51	97.15	-31.32	-79.67
Dividend Per Share, 1 Yr. Growth %	-	-	-	-	8.14
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	20.39	23.94	13.76	20.9	15.11
Gross Profit, 2 Yr. CAGR %	20.26	34.78	15.48	20.59	13.97
EBITDA, 2 Yr. CAGR %	18.29	38.84	13.17	14.51	7.84
EBITA, 2 Yr. CAGR %	20.97	51.86	15.16	16.69	8.58
EBIT, 2 Yr. CAGR %	21.64	53.26	16.06	17.97	9.59
Earnings From Cont. Operations, 2 Yr. CAGR %	19.69	34.86	5.25	0.96	6.26
Net Income, 2 Yr. CAGR %	19.71	34.86	5.09	0.64	6.09
Normalized Net Income, 2 Yr. CAGR %	13.46	56.61	8.7	7.11	11.08
Diluted EPS Before Extra, 2 Yr. CAGR %	14.56	30.93	-7.42	-0	20.18
Accounts Receivable, 2 Yr. CAGR %	17.2	11.6	16.26	21.47	7.98
Inventory, 2 Yr. CAGR %	21.27	10.32	13.66	19.62	5.56
Net Property, Plant and Equip., 2 Yr. CAGR %	18.24	18.05	7.97	15.08	9.14
Total Assets, 2 Yr. CAGR %	20.47	18.51	12.73	14.74	3.92
Tangible Book Value, 2 Yr. CAGR %	-39.28	-1.34	268	146	-32.83
Common Equity, 2 Yr. CAGR %	16.49	17.2	7.12	7.48	6.49
Cash From Operations, 2 Yr. CAGR %	38.53	38.22	17.35	-10.69	-0.97
Capital Expenditures, 2 Yr. CAGR %	62.26	12.17	-18.42	14.98	41.52
Levered Free Cash Flow, 2 Yr. CAGR %	27.71	52.48	78.23	-38.74	-66.13
Unlevered Free Cash Flow, 2 Yr. CAGR %	29.67	49.79	75.04	-18.44	-40.94
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	22.18	18.09	20.68	18.25	14.87
Gross Profit, 3 Yr. CAGR %	19.55	17.69	27.16	18.16	14.81
EBITDA, 3 Yr. CAGR %	19.03	18.37	29.21	13.82	11.59
EBITA, 3 Yr. CAGR %	16.37	19.81	36.34	14.51	12.48
EBIT, 3 Yr. CAGR %	16.61	20.36	37.25	15.13	13.23
Earnings From Cont. Operations, 3 Yr. CAGR %	10.23	17.68	20.99	5.05	3.21
Net Income, 3 Yr. CAGR %	11.51	17.7	20.86	4.84	2.99
Normalized Net Income, 3 Yr. CAGR %	13.75	15.68	32.15	8.37	8.76
Diluted EPS Before Extra, 3 Yr. CAGR %	8.23	14.47	8.74	4.55	2.7
Accounts Receivable, 3 Yr. CAGR %	28.47	12.03	18.04	14.73	15.47
Inventory, 3 Yr. CAGR %	24.9	13.03	16.99	12.01	13.6
Net Property, Plant and Equip., 3 Yr. CAGR %	32.57	12.64	16.7	10.63	10.75
Total Assets, 3 Yr. CAGR %	29.4	14.37	20.08	10.71	10.01
Tangible Book Value, 3 Yr. CAGR %	-64.49	-18.24	107.18	107.78	60.35
Common Equity, 3 Yr. CAGR %	13.35	13.29	13.73	7.37	6.69
Cash From Operations, 3 Yr. CAGR %	25.17	32.35	29.62	-1.23	3.79
Capital Expenditures, 3 Yr. CAGR %	36.96	16.23	11.98	-7.62	30.74
Levered Free Cash Flow, 3 Yr. CAGR %	10	41.58	59.11	-14.68	-54.78
Unlevered Free Cash Flow, 3 Yr. CAGR %	13.66	39.96	59.16	1.11	-30.35
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	17.85	18.68	18.85	19.2	18.42
Gross Profit, 5 Yr. CAGR %	19.6	17.14	16.86	17.95	21.5
EBITDA, 5 Yr. CAGR %	23.14	17.57	17.47	16.4	21.35
EBITA, 5 Yr. CAGR %	24.77	15.97	15.27	16.44	24.57
EBIT, 5 Yr. CAGR %	24.6	16.23	15.52	16.81	25.03
Earnings From Cont. Operations, 5 Yr. CAGR %	27.32	11.73	8.21	10.68	14.87
Net Income, 5 Yr. CAGR %	27.96	11.85	8.9	10.55	14.72
Normalized Net Income, 5 Yr. CAGR %	23.65	13.61	10.74	9.43	22.76
Diluted EPS Before Extra, 5 Yr. CAGR %	18.07	3.71	1.68	8.45	13.18
Accounts Receivable, 5 Yr. CAGR %	15.65	14.77	23.44	15.71	13.9
Inventory, 5 Yr. CAGR %	9.64	12.53	20.28	15.62	12.27
Net Property, Plant and Equip., 5 Yr. CAGR %	21.69	19.78	22.12	13.61	13.62
Total Assets, 5 Yr. CAGR %	29.68	24.46	22.45	14.52	13.33
Tangible Book Value, 5 Yr. CAGR %	-36.44	-27.65	-9.52	27.03	32.03
Common Equity, 5 Yr. CAGR %	27.68	23.98	10.82	10.93	10.78
Cash From Operations, 5 Yr. CAGR %	24.07	10.35	21.98	13.09	16.39
Capital Expenditures, 5 Yr. CAGR %	37.71	40.47	11.32	15.73	22.97
Levered Free Cash Flow, 5 Yr. CAGR %	16.16	8.32	32.03	-0.79	-27.95
Unlevered Free Cash Flow, 5 Yr. CAGR %	18.31	9.71	33.89	10.7	-7.13